Literature DB >> 22156783

Use of complementary and alternative medicine by males with Duchenne or Becker muscular dystrophy.

Sarah K Nabukera1, Paul A Romitti, Kimberly A Campbell, F John Meaney, Kristin M Caspers, Katherine D Mathews, Stacey M Hockett Sherlock, Soman Puzhankara, Christopher Cunniff, Charlotte M Druschel, Shree Pandya, Dennis J Matthews, Emma Ciafaloni.   

Abstract

Use of complementary and alternative medicine by males with Duchenne or Becker muscular dystrophy was examined using interview reports from caregivers enrolled in the population-based Muscular Dystrophy Surveillance, Tracking, and Research Network. Of the 200 caregivers interviewed, 160 (80%) reported "ever" using complementary and alternative medicine for their affected children. Mind-body medicine (61.5%) was most frequently used, followed by biologically based practices (48.0%), manipulative and body-based practices (29.0%), and whole medical systems (8.5%). Caregivers reporting use of whole medical systems had higher education and income levels compared with nonusers; affected males had shorter disease duration. Caregivers reporting use of mind-body medicine, excluding aquatherapy, had higher education level compared with nonusers. Overall, complementary and alternative medicine use was high; disease duration, education, and income levels influenced use. These findings have implications for developing clinical care protocols and monitoring possible interactions between complementary and alternative medicine and conventional medical therapies.

Entities:  

Mesh:

Year:  2011        PMID: 22156783      PMCID: PMC5882202          DOI: 10.1177/0883073811426501

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  26 in total

Review 1.  Complementary and alternative medicine in rheumatology.

Authors:  E Ernst
Journal:  Baillieres Best Pract Res Clin Rheumatol       Date:  2000-12       Impact factor: 4.098

2.  Duchenne muscular dystrophy.

Authors:  Stefan Spies; Karen Schipper; Frans Nollet; Tineke A Abma
Journal:  BMJ       Date:  2010-09-07

3.  Use of complementary and alternative medicine among USA adults with functional limitations: for treatment or general use?

Authors:  Catherine A Okoro; Guixiang Zhao; Chaoyang Li; Lina S Balluz
Journal:  Complement Ther Med       Date:  2011-07-14       Impact factor: 2.446

4.  Pediatric patients with sickle cell disease: use of complementary and alternative therapies.

Authors:  Erica M S Sibinga; Deborah L Shindell; James F Casella; Anne K Duggan; Modena H Wilson
Journal:  J Altern Complement Med       Date:  2006-04       Impact factor: 2.579

5.  Religious faith in Mexican-American families dealing with chronic childhood illness.

Authors:  R S Rehm
Journal:  Image J Nurs Sch       Date:  1999

6.  The muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): surveillance methodology.

Authors:  Lisa A Miller; Paul A Romitti; Christopher Cunniff; Charlotte Druschel; Katherine D Mathews; F John Meaney; Dennis Matthews; Jiji Kantamneni; Zhen-Fang Feng; Nancy Zemblidge; Timothy M Miller; Jennifer Andrews; Deborah Fox; Emma Ciafaloni; Shree Pandya; April Montgomery; Aileen Kenneson
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2006-11

7.  The use of complementary and alternative health care practices among children.

Authors:  Deborah G Loman
Journal:  J Pediatr Health Care       Date:  2003 Mar-Apr       Impact factor: 1.812

Review 8.  Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care.

Authors:  Katharine Bushby; Richard Finkel; David J Birnkrant; Laura E Case; Paula R Clemens; Linda Cripe; Ajay Kaul; Kathi Kinnett; Craig McDonald; Shree Pandya; James Poysky; Frederic Shapiro; Jean Tomezsko; Carolyn Constantin
Journal:  Lancet Neurol       Date:  2009-11-27       Impact factor: 44.182

9.  Factors influencing complementary and alternative medicine use in a multisite pediatric oncology practice.

Authors:  Ian Nathanson; Eric Sandler; Gabriela Ramírez-Garnica; Stacey Armatti Wiltrout
Journal:  J Pediatr Hematol Oncol       Date:  2007-10       Impact factor: 1.289

10.  Factors associated with pediatric use of complementary and alternative medicine.

Authors:  Gurjeet S Birdee; Russell S Phillips; Roger B Davis; Paula Gardiner
Journal:  Pediatrics       Date:  2010-01-25       Impact factor: 7.124

View more
  7 in total

1.  Prevalence of Duchenne and Becker muscular dystrophies in the United States.

Authors:  Paul A Romitti; Yong Zhu; Soman Puzhankara; Katherine A James; Sarah K Nabukera; Gideon K D Zamba; Emma Ciafaloni; Christopher Cunniff; Charlotte M Druschel; Katherine D Mathews; Dennis J Matthews; F John Meaney; Jennifer G Andrews; Kristin M Caspers Conway; Deborah J Fox; Natalie Street; Melissa M Adams; Julie Bolen
Journal:  Pediatrics       Date:  2015-02-16       Impact factor: 7.124

2.  Complementary and alternative medicine for Duchenne and Becker muscular dystrophies: characteristics of users and caregivers.

Authors:  Yong Zhu; Paul A Romitti; Kristin M Conway; Jennifer Andrews; Ke Liu; F John Meaney; Natalie Street; Soman Puzhankara; Charlotte M Druschel; Dennis J Matthews
Journal:  Pediatr Neurol       Date:  2014-02-15       Impact factor: 3.372

3.  Genitourinary health in a population-based cohort of males with Duchenne and Becker Muscular dystrophies.

Authors:  Yong Zhu; Paul A Romitti; Kristin M Caspers Conway; Sunkyung Kim; Ying Zhang; Michele Yang; Katherine D Mathews
Journal:  Muscle Nerve       Date:  2015-06-03       Impact factor: 3.217

Review 4.  A Review of MD STAR net's Research Contributions to Pediatric-Onset Dystrophinopathy in the United States; 2002-2017.

Authors:  Kashika M Sahay; Tiffany Smith; Kristin M Conway; Paul A Romitti; Molly M Lamb; Jennifer Andrews; Shree Pandya; Joyce Oleszek; Christopher Cunniff; Rodolfo Valdez
Journal:  J Child Neurol       Date:  2018-10-22       Impact factor: 1.987

5.  High prevalence of complementary and alternative medicine use in patients with genetically proven mitochondrial disorders.

Authors:  Sebastian Franik; Hidde H Huidekoper; Gepke Visser; Maaike de Vries; Lonneke de Boer; Marion Hermans-Peters; Richard Rodenburg; Chris Verhaak; Arine M Vlieger; Jan A M Smeitink; Mirian C H Janssen; Saskia B Wortmann
Journal:  J Inherit Metab Dis       Date:  2014-10-11       Impact factor: 4.982

6.  Palliative care services in families of males with muscular dystrophy: Data from MD STARnet.

Authors:  Jennifer G Andrews; Shree Pandya; Christina Trout; Treeva Jaff; Dennis Matthews; Christopher Cunniff; F John Meaney
Journal:  SAGE Open Med       Date:  2019-03-27

Review 7.  Nutraceuticals and Their Potential to Treat Duchenne Muscular Dystrophy: Separating the Credible from the Conjecture.

Authors:  Keryn G Woodman; Chantal A Coles; Shireen R Lamandé; Jason D White
Journal:  Nutrients       Date:  2016-11-09       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.